Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR (Bill Only)
Use
This test is used for detecting Helicobacter pylori infection and predicting clarithromycin resistance. The identification of H. pylori is crucial for patients with suspected peptic ulcers, gastritis, or gastric cancer, as it guides appropriate antibiotic therapy. Clarithromycin resistance prediction helps in tailoring treatment regimens, thereby improving therapeutic outcomes and preventing complications associated with resistant strains.
Special Instructions
This test is for billing purposes only and is not orderable directly. It serves to provide billing information only for procedures related to Helicobacter pylori detection with clarithromycin resistance prediction. As such, there are no collection or processing instructions provided, and it relies on existing orderable tests for specimen collection and processing.
Limitations
This test does not include the ability to order Helicobacter pylori detection directly at this time and cannot be used independently for clinical diagnostics. The focus is exclusively on billing for clarithromycin resistance prediction. As a result, clinical considerations such as cross-reactivity, false positives, or false negatives related to H. pylori PCR testing are not addressed.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided